
ALLK
NGSAllakos Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Thursday 15th May 2025
0.33
0.00 (-0.06%)
Prev Close:0.3293
Open:0.3283
Bid:0.3285
Ask:0.33
52 Week Range
0.221.56
Volume:1,215,891
Mkt Cap:30 M
47
MarketXLS Rank ®
Hold
Price Target
$0.38
+15.5%
Financial Statements
ALLK - Balance Sheet (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Invalid date | |
---|---|---|---|---|---|---|---|---|
Accounts Payable | 5 M | 2 M | 5 M | 14 M | 14 M | 6 M | 2 M | |
Accrued Expenses | 18 M | 37 M | 30 M | 40 M | 22 M | 13 M | 5 M | |
Accumulated Depreciation & Depletion | -27 M | -14 M | -8 M | -6 M | -4 M | -2 M | -635000.0 | |
Additional Paid In Capital | 1,313 M | 1,287 M | 1,243 M | 1,058 M | 997 M | 685 M | 288 M | |
Cash And Equivalents | 18 M | 66 M | 87 M | 153 M | 207 M | 38 M | 34 M | |
Cash Cash Equivalents And Short Term Investments | 81 M | 171 M | 280 M | 424 M | 659 M | 496 M | 179 M | |
Cash Equivalents | 659 M | 496 M | 179 M | |||||
Common Par | 90000.0 | 88000.0 | 85000.0 | 54000.0 | 53000.0 | 48000.0 | 42000.0 | |
Common Stock Equity | 79 M | 169 M | 310 M | 445 M | 654 M | 496 M | 184 M | |
Common Stock | 90000.0 | 88000.0 | 85000.0 | 54000.0 | 53000.0 | 48000.0 | 42000.0 | |
Current Accrued Expenses | 12 M | 35 M | 25 M | 27 M | 8 M | 7 M | 3 M | |
Current Capital Lease Obligation | 4 M | 3 M | 3 M | 2 M | 492000.0 | 410000.0 | 403000.0 | |
Current Deferred Taxes Assets | 7 M | 9 M | 7 M | 9 M | 2 M | 65000.0 | ||
Current Deferred Taxes Liabilities | 7 M | 9 M | 7 M | 9 M | 395000.0 | 65000.0 | ||
Float Term Debt | 38 M | 46 M | 49 M | 43 M | ||||
Gross Fixed Assets (plant Property & Equipment) | 38 M | 72 M | 78 M | 81 M | 52 M | 8 M | 9 M | |
Invested Capital | 79 M | 207 M | 356 M | 495 M | 697 M | 496 M | 184 M | |
Long Term Capital Lease Obligation | 4 M | 38 M | 46 M | 49 M | 43 M | 8 M | ||
Long Term Debt And Capital Lease Obligation | 38 M | 46 M | 49 M | 43 M | 8 M | |||
Net Fixed Assets (net PP&E) | 11 M | 58 M | 69 M | 75 M | 48 M | 6 M | 9 M | |
Non Current Deferred Taxes Assets | -402 M | 381 M | 337 M | 210 M | 121 M | 62 M | 29 M | |
Other Current Assets | 16 M | 15 M | 13 M | 12 M | 7 M | 4 M | 2 M | |
Other Equity Adjustments | -153000.0 | 8000.0 | 137000.0 | -15000.0 | ||||
Other Fixed Assets | 11 M | 58 M | 69 M | 75 M | 48 M | 6 M | ||
Other Non-current Assets | 200000.0 | 6 M | 8 M | 8 M | 2 M | 3 M | 802000.0 | |
Other Non-current Liabilities | 8 M | 2 M | ||||||
Other Current Liabilities | 5 M | 6 M | 37 M | 145 M | 9 M | 16 M | ||
Payables | 5 M | 2 M | 5 M | 14 M | 14 M | 6 M | 2 M | |
Preferred Securities Of Subsidiary Trust | 20 M | 20 M | ||||||
Preferred Stock | 20 M | 20 M | ||||||
Prepaid Expenses | 5 M | 9 M | 29 M | 27 M | 10 M | 4 M | 3 M | |
Restricted Cash | 19 M | 68 M | 89 M | 155 M | 209 M | |||
Retained Earnings | -1,234 M | -1,118 M | -933 M | -613 M | -343 M | -189 M | -104 M | |
Total Assets | 97 M | 244 M | 386 M | 535 M | 720 M | 517 M | 191 M | |
Total Current Assets | 86 M | 180 M | 309 M | 452 M | 669 M | 500 M | 182 M | |
Total Current Liabilities | 18 M | 37 M | 30 M | 40 M | 22 M | 13 M | 5 M | |
Total Equity | 79 M | 169 M | 310 M | 445 M | 654 M | 496 M | 184 M | |
Total Liabilities | 18 M | 75 M | 76 M | 89 M | 65 M | 21 M | 7 M | |
Total Non-current Assets | 11 M | 64 M | 78 M | 83 M | 50 M | 9 M | 10 M | |
Total Non-current Liabilities | 38 M | 46 M | 49 M | 43 M | 8 M | 2 M | ||
Total Equity Gross Minority | 79 M | 169 M | 310 M | 445 M | 654 M | 496 M | 184 M | |
Total Equity Gross Minority Interest | 79 M | 169 M | 310 M | 445 M | 654 M | 496 M | 184 M | |
Total Liabilities And Total Equity Gross Minority Interest | 97 M | 244 M | 386 M | 535 M | 720 M | 517 M | 191 M | |
Total Non Current Liabilities Net Minority Interes | 38 M | 46 M | 49 M | 43 M | 8 M | 2 M | ||
Working Capital | 68 M | 143 M | 279 M | 411 M | 647 M | 487 M | 176 M |